Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma

Corresponding Author

Centre Méditerranéen de Médecine Moléculaire (C3M), Université Nice Côte d'Azur, INSERM, Nice, France

Department of Dermatology, Université Nice Côte d'Azur, CHU Nice, Nice, France

*Equally contributing, co-first and co-last authors

Correspondence

Dr Henri Montaudié, MD, PhD, Department of Dermatology and C3M INSERM U1065, 151 route Saint-Antoine de Ginestière, 06200 Nice, France.

Email: montaudie.h@chu-nice.fr

Search for more papers by this author

留言 (0)

沒有登入
gif